rhIL7

rhIL7 refers to recombinant human interleukin-7. Interleukin-7 is a cytokine that plays a crucial role in the development and maintenance of T cells and B cells, key components of the immune system. It is primarily produced by stromal cells in the bone marrow and thymus.

Recombinant human interleukin-7 is a laboratory-produced version of this naturally occurring protein. It is generated through genetic engineering techniques, typically by inserting the human gene for IL-7 into a host cell system, such as bacteria or mammalian cells, which then produces the protein. The "rh" prefix signifies this recombinant, human origin.

rhIL7 is utilized in various research and clinical applications. In research settings, it is used to study T cell development, immune responses, and the mechanisms of certain diseases. Clinically, rhIL7 has been investigated as a therapeutic agent, particularly in contexts where T cell reconstitution is desired, such as after hematopoietic stem cell transplantation or in patients with immunodeficiencies. Its ability to promote lymphocyte proliferation and survival makes it a subject of interest for immune-based therapies.

---